Business Wire

Bentley Systems Issues Call for Nominations for the 2025 Going Digital Awards

17.2.2025 16:01:00 EET | Business Wire | Press release

Share

Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced nominations are now open for the 2025 Going Digital Awards. This renowned global program recognizes the very best digital advancements in infrastructure delivery and performance. Independent jurors—consisting of thought leaders and experts in their field—select the winners from among the world’s most extraordinary infrastructure projects. The deadline for nominations is March 31, 2025.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250217405555/en/

Winners of the 2024 Going Digital Awards celebrate their accomplishments. Nominations are now open for the 2025 awards. Image courtesy of Bentley Systems.

Celebrating over 20 years, the awards program has recognized more than 5,250 of the world's most outstanding infrastructure projects. This global program is open to all Bentley software users and nominations are encouraged across a range of categories, encompassing all forms of infrastructure projects and stages—from design and construction to operations.

Three finalists will be chosen within each of the 12 award categories. Finalists will attend Bentley’s Year in Infrastructure conference and Going Digital Awards program in Amsterdam, October 14-15, 2025, as guests of Bentley. As part of the conference, finalists will win a trip to the Year in Infrastructure and Going Digital Awards to present their projects before an independent jury of industry peers and key members of the press. In addition to the juried awards, Bentley’s founders will honor select projects representing organizations or individuals making meaningful contributions to infrastructure advancement. Winners will be announced on October 15 during the Going Digital Awards ceremony.

The 2025 Going Digital Awards categories include:

  • Bridges and Tunnels​
  • Cities, Campuses, and Facilities
  • Construction​
  • Energy Production
  • Geospatial and Reality Modeling
  • Project Delivery​
  • Rail and Transit​
  • Roads and Highways​
  • Structural Engineering​
  • Subsurface Modeling and Analysis​
  • Transmission and Distribution​
  • Water and Wastewater​

Going Digital Awards projects will also be profiled in Bentley’s Infrastructure Yearbook, which is distributed to an international audience comprised of government officials, industry influencers, media, industry analysts, and Bentley users.

For more information about the 2025 Going Digital Awards program, or to nominate a project, visit the Going Digital Awards website.

# # #

About Bentley Systems

Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, mining, and industrial facilities. Our offerings, powered by the iTwin Platform for infrastructure digital twins, include MicroStation and Bentley Open applications for modeling and simulation, Seequent’s software for geoprofessionals, and Bentley Infrastructure Cloud encompassing ProjectWise for project delivery, SYNCHRO for construction management, and AssetWise for asset operations. Bentley Systems’ 5,200 colleagues generate annual revenues of more than $1 billion in 194 countries.

© 2025 Bentley Systems, Incorporated. Bentley, the Bentley logo, Bentley Open, Bentley Infrastructure Cloud, AssetWise, iTwin, MicroStation, ProjectWise, SYNCHRO, and Seequent are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250217405555/en/

Contacts

For more information, contact:
Press: Chris Phillips, PR@news.bentley.com
Investors: Eric Boyer, IR@bentley.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Techtronic Industries Delivers Strong First Half Performance4.8.2026 14:20:00 EEST | Press release

Techtronic Industries Co. Ltd. (“TTI” or the “Group”) (stock code: HK: 0669, ADR symbol: TTNDY), a global cordless power tool, outdoor power equipment and floorcare & cleaning company, is pleased to announce its results for the six-month period ended June 30, 2026. The Group delivered record first half results in 2026, with revenue growing 5.9% to US$8.3 billion. Its two leading brands, MILWAUKEE and RYOBI, both delivered a strong performance in the first half of 2026, growing at a combined 8.2% underlying growth rate in local currency. TTI delivered record first half results in 2026, with revenue growing 5.9% to US$8.3 billion and net profit increasing 17.5% to US$738 million. Our global MILWAUKEE business grew 10.5% on an underlying basis in local currency, after adjusting for the planned 2025 timing impact related to the MILWAUKEE Americas ERP system conversion. RYOBI, the #1 global consumer cordless tool and outdoor products brand, grew 1.7% in local currency to US$1.9 billion in t

WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership4.8.2026 12:00:00 EEST | Press release

WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804399367/en/ WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership The Natural Cycles app, a Class II medical device, uses biomarker data, including temperature and heart rate data, to identify fertile and non-fertile days, helping users prevent pregnancy without hormones while also providing fertility insights. Beyond birth control, the app

Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 11:00:00 EEST | Press release

Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphatax's long-term vision for the future of tax technology. By bringing these transfer pric

LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 10:10:00 EEST | Press release

LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The

Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 10:00:00 EEST | Press release

Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 years, she has led global teams to achieve a 100% success rate from Phase 3 development through to FDA approval for multiple programs spanning oncology, immunology and respiratory medicine. In addition, she raised funds of around $400M as founder and CEO. Across her career she has contributed to 20 drug approvals, engaging

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye